BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pan W, Zheng X, Chen G, Su L, Luo S, Wang W, Ye S, Weng J, Min Y. Nanotechnology's application in Type 1 diabetes. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2020;12:e1645. [PMID: 32558337 DOI: 10.1002/wnan.1645] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang W, Teng Y, Xue J, Cai H, Pan Y, Ye X, Mao X, Li S. Nanotechnology in Kidney and Islet Transplantation: An Ongoing, Promising Field. Front Immunol 2022;13:846032. [DOI: 10.3389/fimmu.2022.846032] [Reference Citation Analysis]
2 Vemana HP, Dukhande VV. Recent advances in the application of nanomedicine for the treatment of diabetes. Nanomedicine (Lond) 2022;17:65-9. [PMID: 34983192 DOI: 10.2217/nnm-2021-0338] [Reference Citation Analysis]
3 Nigam S, Bishop JO, Hayat H, Quadri T, Hayat H, Wang P. Nanotechnology in Immunotherapy for Type 1 Diabetes: Promising Innovations and Future Advances. Pharmaceutics 2022;14:644. [DOI: 10.3390/pharmaceutics14030644] [Reference Citation Analysis]
4 Han MM, Yuan XR, Shi X, Zhu XY, Su Y, Xiong DK, Zhang XM, Zhou H, Wang JN. The Pathological Mechanism and Potential Application of IL-38 in Autoimmune Diseases. Front Pharmacol 2021;12:732790. [PMID: 34539413 DOI: 10.3389/fphar.2021.732790] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]